Ian Mortimer

Chief Executive Officer en XENON PHARMACEUTICALS INC. .

Fortuna: 2 M $ al 31/03/2024

48 años

Health Technology

Consumer Services

Perfil

Ian C.
Mortimer is currently the President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc. He is also a Director at Perimeter Medical Imaging, Inc. and Perimeter Medical Imaging AI, Inc. Mr. Mortimer previously served as an Independent Director at Appili Therapeutics, Inc. from 2017 to 2020.
Prior to that, he was the Chief Financial Officer & Executive Vice President at Arbutus Biopharma Corp.
from 2007 to 2013.
Mr. Mortimer holds an MBA from Queen's University and an undergraduate degree from the University of British Columbia.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
XENON PHARMACEUTICALS INC. 0.06%	11/03/2024	45 602 ( 0.06% )	2 M $	31/03/2024
PERIMETER MEDICAL IMAGING AI INC 0.17%	03/04/2024	113 333 ( 0.17% )	73 440 $	31/03/2024

Cargos activos de Ian Mortimer

Empresas	Cargo	Inicio
XENON PHARMACEUTICALS INC.	Chief Executive Officer	03/06/2021
PERIMETER MEDICAL IMAGING AI, INC.	Director/Board Member	03/07/2020
Xenon Pharmaceuticals USA, Inc. Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA.	President	-

Todos los cargos activos de Ian Mortimer

Antiguos cargos conocidos de Ian Mortimer.

Empresas	Cargo	Fin
ARBUTUS BIOPHARMA CORPORATION	Director of Finance/CFO	01/10/2013
Perimeter Medical Imaging, Inc. Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada.	Director/Board Member	-
APPILI THERAPEUTICS INC.	Chairman	-

Ver el detalle de la experiencia de Ian Mortimer.

Formación de Ian Mortimer.

Queen's University	Masters Business Admin
University of British Columbia	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Ian Mortimer.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	4
ARBUTUS BIOPHARMA CORPORATION	Health Technology
XENON PHARMACEUTICALS INC.	Health Technology
APPILI THERAPEUTICS INC.	Health Technology
PERIMETER MEDICAL IMAGING AI, INC.	Health Technology

Empresas privadas	2
Perimeter Medical Imaging, Inc. Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada.	Health Technology
Xenon Pharmaceuticals USA, Inc. Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA.	Health Technology